To further investigate the functional expression of these HLA-II molecules, we conducted a neoantigen prediction analysis specifically for HLA-DPB1*05:01-restricted neoantigens [29] using transcriptome and exome data from 104 ESCC patients [16]. This evidence concerns the gene HLA-DPB1 and esophageal squamous cell carcinoma.